Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.SenoRx, a developer and marketer of invasive medical devices, has further extended its international reach to encompass seven additional global markets.
Subscribe to our email newsletter
In addition to the 24 countries where SenoRx products are already being sold, the company will begin marketing EnCor, its vacuum-assisted breast biopsy product, and its GelMark line of breast biopsy tissue markers through distributors in Egypt, Greece, Poland, Saudi Arabia, Thailand, Turkey and the UAE.
SenoRx is partnering with local in-country distributors who have breast imaging or interventional radiology franchises in select markets. SenoRx has previously established partnering relationships with distributors in several countries.
EnCor and SenoRx breast tissue biopsy markers have previously received the necessary regulatory clearances in countries within the European Economic Community and in all of the other countries that SenoRx has established distribution channels.
Lloyd Malchow, SenoRx president and CEO, said: SenoRx continues to expand its international footprint in key markets where breast-care is increasingly becoming a national healthcare priority. We have had positive results with our earlier international expansion initiatives and continue to see attractive opportunities for growth in the global marketplace. With the addition of these seven new geographic markets, SenoRx will now have a presence in more than 30 countries outside North America.